[go: up one dir, main page]

HK1110211B - 2-(2-硝基-4-三氟甲基苯甲酰)-1，3-环己二酮在治疗帕金森氏病中的应用 - Google Patents

2-(2-硝基-4-三氟甲基苯甲酰)-1，3-环己二酮在治疗帕金森氏病中的应用 Download PDF

Info

Publication number
HK1110211B
HK1110211B HK08101077.6A HK08101077A HK1110211B HK 1110211 B HK1110211 B HK 1110211B HK 08101077 A HK08101077 A HK 08101077A HK 1110211 B HK1110211 B HK 1110211B
Authority
HK
Hong Kong
Prior art keywords
compound
effective amount
pharmaceutically acceptable
pharmaceutically effective
acceptable salt
Prior art date
Application number
HK08101077.6A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1110211A1 (zh
Inventor
John Ernest Doe
Nicholas Crispinian Sturgess
Kim Zachary Travis
Original Assignee
Syngenta Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0504103.3A external-priority patent/GB0504103D0/en
Application filed by Syngenta Limited filed Critical Syngenta Limited
Publication of HK1110211A1 publication Critical patent/HK1110211A1/zh
Publication of HK1110211B publication Critical patent/HK1110211B/zh

Links

HK08101077.6A 2005-02-28 2006-02-27 2-(2-硝基-4-三氟甲基苯甲酰)-1，3-环己二酮在治疗帕金森氏病中的应用 HK1110211B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0504103.3 2005-02-28
GBGB0504103.3A GB0504103D0 (en) 2005-02-28 2005-02-28 Novel method
PCT/GB2006/000684 WO2006090177A1 (en) 2005-02-28 2006-02-27 USE OF 2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-l,3- CYCLOHEXANEDIONE IN THE TREATMENT OF PARKINSON'S DISEASE

Publications (2)

Publication Number Publication Date
HK1110211A1 HK1110211A1 (zh) 2008-07-11
HK1110211B true HK1110211B (zh) 2012-06-08

Family

ID=

Similar Documents

Publication Publication Date Title
Bakun et al. In vitro and in vivo biological activities of azulene derivatives with potential applications in medicine
JP2022037132A (ja) 筋萎縮性側索硬化症患者の下位集団の治療のためのマシチニブの使用
EP3444249B1 (en) Sodium channel blockers, preparation method thereof and use thereof
JP2015504871A (ja) グリタゾンおよびｎｒｆ２アクチベーターを含む医薬組成物
EP1853241B1 (en) Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3- cyclohexanedione in the treatment of parkinson's disease
DE19948417A1 (de) Imidazol-Derivate und ihre Verwendung als Arzneimittel
EP4452939A1 (en) Polypodal serotonergic compounds and prodrugs of serotonin receptor agonists and antagonists
JP5363636B2 (ja) 新規な塩および医学的使用
JP7512206B2 (ja) ミトコンドリア障害を処置するための方法
KR101497868B1 (ko) 리모닌을 유효성분으로 포함하는 혈관근육세포의 증식과 관련된 질환의 예방 및 치료용 약제학적 조성물
HK1110211B (zh) 2-(2-硝基-4-三氟甲基苯甲酰)-1，3-环己二酮在治疗帕金森氏病中的应用
EP2233136A1 (en) Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs
JP2015512407A (ja) 動脈硬化性血管疾患を処置するための方法及び組成物
HK1142836A (zh) Hppd 抑制剂在治疗抑郁症和/或与成瘾药物有关的戒断症状中的用途
KR20010086473A (ko) 류코트리엔 생성 저해활성을 가지는 정유 성분
KR20250024570A (ko) 골질환 예방 또는 치료용 약학 조성물
JP2007529548A (ja) 抗ｈｉｖベンズアミド化合物およびベンゾアート化合物
JP2019189558A (ja) 局所的炎症の抑制剤
KR20130083096A (ko) 아니솔 유도체를 유효성분으로 포함하는 염증질환 예방 및 치료용 조성물
JP2011032267A (ja) １１βＨＳＤ１阻害剤およびその用途